176 related articles for article (PubMed ID: 17917290)
21. Inclusion complex of trimethoprim with beta-cyclodextrin.
Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
[TBL] [Abstract][Full Text] [Related]
22. Sildenafil/cyclodextrin complexation: stability constants, thermodynamics, and guest-host interactions probed by 1H NMR and molecular modeling studies.
Al Omari MM; Zughul MB; Davies JE; Badwan AA
J Pharm Biomed Anal; 2006 Jun; 41(3):857-65. PubMed ID: 16527440
[TBL] [Abstract][Full Text] [Related]
23. Complexation of celecoxib with beta-cyclodextrin: characterization of the interaction in solution and in solid state.
Sinha VR; Anitha R; Ghosh S; Nanda A; Kumria R
J Pharm Sci; 2005 Mar; 94(3):676-87. PubMed ID: 15668949
[TBL] [Abstract][Full Text] [Related]
24. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
25. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
26. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
Pescitelli G; Bilia AR; Bergonzi MC; Vincieri FF; Di Bari L
J Pharm Biomed Anal; 2010 Aug; 52(4):479-83. PubMed ID: 20185265
[TBL] [Abstract][Full Text] [Related]
27. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
Miyake K; Hirayama F; Uekama K
J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
[TBL] [Abstract][Full Text] [Related]
28. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative.
Ishiguro T; Morishita E; Iohara D; Hirayama F; Wada K; Motoyama K; Arima H; Uekama K
Int J Pharm; 2011 Oct; 419(1-2):161-9. PubMed ID: 21839823
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach.
Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Ishiguro T; Hirayama F; Uekama K; Otagiri M
J Pharm Sci; 2010 Oct; 99(10):4285-94. PubMed ID: 20737636
[TBL] [Abstract][Full Text] [Related]
30. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
Jug M; Kosalec I; Maestrelli F; Mura P
J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
[TBL] [Abstract][Full Text] [Related]
31. Physical-chemical characterization of binary systems of metformin hydrochloride with triacetyl-beta-cyclodextrin.
Corti G; Capasso G; Maestrelli F; Cirri M; Mura P
J Pharm Biomed Anal; 2007 Nov; 45(3):480-6. PubMed ID: 17822867
[TBL] [Abstract][Full Text] [Related]
32. Interactions between lonidamine and beta- or hydroxypropyl-beta-cyclodextrin.
Palmieri GF; Wehrlé P; Martelli S
Drug Dev Ind Pharm; 1998 Jul; 24(7):653-60. PubMed ID: 9876510
[TBL] [Abstract][Full Text] [Related]
33. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
[TBL] [Abstract][Full Text] [Related]
34. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
35. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
Ozdemir N; Ordu S
Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
[TBL] [Abstract][Full Text] [Related]
36. Improvement of the Ocular Bioavailability of Econazole Nitrate upon Complexation with Cyclodextrins.
Abd El-Gawad AEH; Soliman OA; El-Dahan MS; Al-Zuhairy SAS
AAPS PharmSciTech; 2017 Jul; 18(5):1795-1809. PubMed ID: 27830515
[TBL] [Abstract][Full Text] [Related]
37. [The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex].
Zhang YM; Li X; Sun CS; Chen CF
Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Mar; 28(3):711-4. PubMed ID: 18536450
[TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
Desai C; Prabhakar B
Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
[TBL] [Abstract][Full Text] [Related]
39. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
40. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.
Veiga MD; Ahsan F
Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]